Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04464772 · ClinicalTrials.gov registry record
FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study
A clinical trial of Diabetes Mellitus, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 85
- Enrollment target
- 4
- Study locations
NCT04464772: Completed study of Diabetes Mellitus, sponsored by Abbott Diabetes Care.
NCT04464772 is a study of Diabetes Mellitus that has completed, run by Abbott Diabetes Care. The registered enrollment target is 85 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04464772, a study of Diabetes Mellitus, has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to characterize the Freestyle Libre Glucose Monitoring System in pediatric and adult subjects with respect to YSI reference venous plasma sample measurements.
Primary Outcome
System Performance will be characterized with respect to YSI reference venous plasma measurements
Conditions Studied
Interventions
- DEVICE FreeStyle Libre 3
Study Locations (4)
California
- AMCR Institute - Escondido
- Sansum Diabetes Research Institute - Santa Barbara
Idaho
- Rocky Mountain Diabetes & Osteoporosis Center - Idaho Falls
Washington
- Rainier Clinical Research - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2020-07-10 |
| Est. Completion | 2020-09-22 |
What the finished NCT04464772 record still lists
NCT04464772 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which FreeStyle Libre 3 is the first listed.
NCT04464772 reports a single indexed study location in California, Idaho, Washington.
Frequently Asked Questions
What is clinical trial NCT04464772 about?
NCT04464772 is a clinical study titled "FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study". The purpose of this study is to characterize the Freestyle Libre Glucose Monitoring System in pediatric and adult subjects with respect to YSI reference venous plasma sample measurements.
What is the current status of trial NCT04464772?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2020-07-10. Estimated completion is 2020-09-22.
What conditions does trial NCT04464772 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT04464772?
The interventions under investigation include: FreeStyle Libre 3 (DEVICE).
Who is sponsoring clinical trial NCT04464772?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04464772 being conducted?
This trial has 4 study locations across California, Idaho, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04464772's enrollment target sits among peer trials
85 130th of 208 higher than 77 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI